Int J Biol Sci
2020; 16(15):3037-3038.
doi:10.7150/ijbs.53769 This issueCite
Erratum
Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum
Fei Han, Mei Xue, Yunpeng Chang, Xiaoyu Li, Yang Yang, Bei Sun✉, Liming Chen✉
Key Laboratory of Hormones and Development (Ministry of Health), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University
✉ Corresponding authors
Citation:
Han F, Xue M, Chang Y, Li X, Yang Y, Sun B, Chen L. Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum. Int J Biol Sci 2020; 16(15):3037-3038. doi:10.7150/ijbs.53769. https://www.ijbs.com/v16p3037.htm
Han, F., Xue, M., Chang, Y., Li, X., Yang, Y., Sun, B., Chen, L. (2020). Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum. International Journal of Biological Sciences, 16(15), 3037-3038. https://doi.org/10.7150/ijbs.53769.
ACS
Han, F.; Xue, M.; Chang, Y.; Li, X.; Yang, Y.; Sun, B.; Chen, L. Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum. Int. J. Biol. Sci. 2020, 16 (15), 3037-3038. DOI: 10.7150/ijbs.53769.
NLM
Han F, Xue M, Chang Y, Li X, Yang Y, Sun B, Chen L. Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum. Int J Biol Sci 2020; 16(15):3037-3038. doi:10.7150/ijbs.53769. https://www.ijbs.com/v16p3037.htm
CSE
Han F, Xue M, Chang Y, Li X, Yang Y, Sun B, Chen L. 2020. Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum. Int J Biol Sci. 16(15):3037-3038.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.